Methods for proliferation of antigen-specific T cells
View Patent ↗Methods for expansion of antigen-specific T cells are provided. Said methods include following steps: generating antigen-specific T cells by stimulation of T cells with antigen A; introducing genes encoding immune recognition molecule specific to major histocompatibility complex (MHC) molecule bound with a peptide derived from antigen B into the antigen A specific T cell to produce bi-specific T cells recognizing both target cells expressing antigen A peptide associated MHC and target cells expressing antigen B peptide associated MHC; stimulating the bi-specific T cells by antigen A for expansion of the bi-specific T cells in vitro or in vivo. Methods of the present invention can be applied to expand various of T cells with specific to cancer cells with tumor antigen peptide loaded MHC molecules for adoptive therapy against unmet medical need such as tumors etc.
1. A method for expanding bi-specific T cells, comprising:
(1) stimulating T cells with antigen A to generate T cells specific to a peptide-MHC complex of antigen A,
(2) transferring a gene encoding an immune recognition molecule for targeting a peptide-MHC complex of antigen B into the T-cells specific to the peptide-MHC complex of antigen A to obtain bi-specific T-cells that are specific to both antigen A and antigen B, and
(3) stimulating the bi-specific T-cells with antigen A, thereby expanding the bi-specific T-cells,
wherein antigen A is a virus, bacterium, amino acid peptide, chimeric protein, or allogeneic antigen with more than 7 and less than 35 amino acids,
wherein the immune recognition molecule for targeting a peptide-MHC complex of antigen B is melanoma differentiation antigen gp100-specific T cell receptor (TCR), and
wherein the gene encoding melanoma differentiation antigen gp 100-specific TCR comprises SEQ ID NO: 1 encoding the TCR α subunit and SEQ ID NO:2 encoding the TCR β subunit.
2. The method of claim 1 , wherein step (3) is performed in vitro or/and in vivo.
3. The method of claim 1 , wherein step (3) is performed by:
(a) transfusing antigen B-specific T-cells into a living object immunized with antigen A,
(b) culturing antigen B-specific T-cells in the presence of antigen A, or
(c) co-culturing antigen B-specific T-cells and feeder cells in the presence of antigen A.
4. The method of claim 1 , wherein step (2) is performed using a viral vector, liposome, cationic polymer, or electroporation.
5. The method of claim 4 , wherein the viral vector is a retroviral vector, lentiviral vector, or adeno-associated viral vector.
6. The method of claim 4 , wherein step (2) is performed by:
(a) co-culturing recombinant virus packaging cells and antigen A-specific T-cells in the presence of antigen A or its derived peptide,
(b) co-culturing recombinant virus packaging cells, antigen A-specific T-cells, and feeder cells expressing antigen A or pulsed with antigen A-derived peptide;
(c) co-culturing recombinant virus and antigen A-specific T-cells in the presence of antigen A or antigen A-derived peptide; or
(d) co-culturing recombinant virus, antigen A-specific T-cells, and feeder cells expressing antigen A or pulsed with antigen A-derived peptide;
wherein the recombinant virus comprises a gene encoding an immune recognition molecule that recognizes antigen B peptide-MHC complex.
7. The method of claim 1 , wherein the virus is influenza virus, EB virus, or CMV virus.
8. The method of claim 1 , wherein the T-cells specific to the peptide-MHC complex of antigen A are generated by immunizing animals with antigen A.
9. The method of claim 1 , wherein the gene encoding the immune recognition molecule is transferred by (a) viral vectors selected from the group consisting of retroviral vectors, lentiviral vectors and adeno-associated virus vectors, (b) liposomes, (c) cationic polymers, or (d) electroporation.
10. The method of claim 1 , wherein the gene encoding the immune recognition molecule is transferred by:
a. co-culturing packaging cells that produce recombinant virus with antigen A-specific T cells and antigen A;
b. co-culturing packaging cells that package recombinant virus with antigen A-specific T cells and feeder cells expressing MHC associated with a peptide of antigen A;
c. co-culturing recombinant virus, antigen A-specific T cells, and antigen A; or
d. co-culturing recombinant virus, antigen A-specific T cells, and feeder cells expressing MHC associated a peptide from antigen A;
wherein the recombinant virus contains the gene encoding an immune recognition molecules for targeting a peptide-MHC complex of antigen B.